Janel Long‐Boyle
Biographic Data
| ID | 8260593 |
|---|---|
| NAME | Janel Long‐Boyle |
| GIVEN NAMES | Janel |
| FAMILY NAME | Long‐Boyle |
| SIGNATURE | BOYLE J L |
| AFFILIATIONS | University of California, San Francisco |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibility, safety, and neuroprotective efficacy of clemastine administration in near-term lambs ( n = 25, 141-143 days) following a global ischemic insult i…
No prominent works on this page.
Effect of Clemastine on Neurophysiological Outcomes in an Ovine Model of Neonatal Hypoxic-Ischemic Encephalopathy
Originally approved by the U.S. Food and Drug Administration (FDA) for its antihistamine properties, clemastine can also promote white matter integrity and has shown promise in the treatment of demyelinating diseases such as multiple sclerosis. Here, we conducted an in-depth analysis of the feasibility, safety, and neuroprotective efficacy of clemastine administration in near-term lambs ( n = 25, 141-143 days) following a global ischemic insult i…
Anesthesia (1 work) · Anesthesia and Neurotoxicity Research (1 work) · Cardiology (1 work) · Chemistry (1 work) · Encephalopathy (1 work) · Hypoxia (environmental (1 work) · Hypoxic-Ischemic Encephalopathy (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Metabolism and Genetic Disorders (1 work)